[8-K] Jaguar Health, Inc. Reports Material Event
Jaguar Health, Inc. announced a Sixth Amendment to its At-The-Market (ATM) Offering Agreement that extends Lucid Capital Markets, LLC's role as a Manager under the agreement. The amendment extends Lucid's term retrospectively from June 30, 2025 to December 31, 2025, unless the parties agree to a further extension.
The amendment clarifies that if the agreement is not otherwise amended or extended, Ladenburg Thalmann & Co. Inc. will remain as the sole Manager after December 31, 2025. The company also filed a prospectus supplement (referencing the May 23, 2024 supplement and May 1, 2024 prospectus) relating to the amendment, and attached the full amendment as Exhibit 10.1.
Jaguar Health, Inc. ha annunciato il sesto emendamento al suo accordo di offerta At-The-Market (ATM) che estende il ruolo di Lucid Capital Markets, LLC come Manager nell'ambito dell'accordo. L'emendamento estende retroattivamente il periodo di Lucid dal 30 giugno 2025 al 31 dicembre 2025, salvo ulteriore proroga concordata dalle parti.
L'emendamento chiarisce che, qualora l'accordo non venga altrimenti modificato o prorogato, Ladenburg Thalmann & Co. Inc. rimarr脿 l'unico Manager dopo il 31 dicembre 2025. La societ脿 ha inoltre depositato un supplemento al prospetto (con riferimento al supplemento del 23 maggio 2024 e al prospetto del 1掳 maggio 2024) relativo all'emendamento, allegando il testo integrale dell'emendamento come Exhibit 10.1.
Jaguar Health, Inc. anunci贸 una sexta enmienda a su Acuerdo de Oferta At-The-Market (ATM) que ampl铆a el papel de Lucid Capital Markets, LLC como gestor dentro del acuerdo. La enmienda prorroga retroactivamente el plazo de Lucid desde el 30 de junio de 2025 hasta el 31 de diciembre de 2025, salvo que las partes acuerden una pr贸rroga adicional.
La enmienda aclara que, si el acuerdo no se modifica ni se ampl铆a de otro modo, Ladenburg Thalmann & Co. Inc. seguir谩 siendo el 煤nico gestor despu茅s del 31 de diciembre de 2025. La compa帽铆a tambi茅n present贸 un suplemento al prospecto (haciendo referencia al suplemento del 23 de mayo de 2024 y al prospecto del 1 de mayo de 2024) relacionado con la enmienda, y adjunt贸 la enmienda completa como Exhibit 10.1.
Jaguar Health, Inc.電� At-The-Market(ATM) 瓿惦瓿勳暯鞐� 雽�頃� 鞝�6彀� 靾橃爼鞎堨潉 氚滍憸頄堨溂氅�, 鞚� 靾橃爼鞎堨潃 頃措嫻 瓿勳暯鞐愳劀 Lucid Capital Markets, LLC鞚� 毵る媹鞝� 鞐暊鞚� 鞐办灔頃╇媹雼�. 靾橃爼鞎堨潃 2025雲� 6鞗� 30鞚�攵赌韯� 2025雲� 12鞗� 31鞚�旯岇 Lucid鞚� 旮瓣皠鞚� 靻岅笁頃橃棳 鞐办灔頃橂┌, 雼轨偓鞛愲摛鞚� 於旉岸� 鞐办灔鞐� 頃╈潣頃橃 鞎婋姅 頃� 鞙犿毃頃╇媹雼�.
靾橃爼鞎堨潃 瓿勳暯鞚� 雼Μ 靾橃爼霅橁卑雮� 鞐办灔霅橃 鞎婋姅 瓴届毎 Ladenburg Thalmann & Co. Inc.臧赌 2025雲� 12鞗� 31鞚� 鞚错泟鞐愲弰 雼弲 毵る媹鞝�搿� 雮姅雼る姅 鞝愳潉 氇呿檿頌� 頃╇媹雼�. 須岇偓電� 霕愴暅 頃措嫻 靾橃爼鞎堦臣 甏�霠悳 歃濌秾靹る獏靹� 氤挫订靹�(2024雲� 5鞗� 23鞚� 氤挫订靹� 氚� 2024雲� 5鞗� 1鞚� 歃濌秾靹る獏靹滊ゼ 彀胳“)毳� 鞝滌稖頃橁碃, 鞝勳泊 靾橃爼鞎堨潉 Exhibit 10.1搿� 觳秬頄堨姷雼堧嫟.
Jaguar Health, Inc. a annonc茅 un sixi猫me amendement 脿 son accord d'offre At-The-Market (ATM) qui prolonge le r么le de Lucid Capital Markets, LLC en tant que Manager dans le cadre de l'accord. L'amendement prolonge r茅troactivement la dur茅e de Lucid du 30 juin 2025 au 31 d茅cembre 2025, sauf accord des parties pour une prolongation suppl茅mentaire.
L'amendement pr茅cise que, si l'accord n'est pas modifi茅 ou prolong茅 autrement, Ladenburg Thalmann & Co. Inc. restera le seul Manager apr猫s le 31 d茅cembre 2025. La soci茅t茅 a 茅galement d茅pos茅 un suppl茅ment au prospectus (faisant r茅f茅rence au suppl茅ment du 23 mai 2024 et au prospectus du 1er mai 2024) relatif 脿 l'amendement, et a joint l'amendement complet en tant qu'Exhibit 10.1.
Jaguar Health, Inc. hat eine sechste 脛nderung ihres At-The-Market-(ATM)-Angebotsvertrags angek眉ndigt, die die Rolle von Lucid Capital Markets, LLC als Manager im Rahmen des Vertrags verl盲ngert. Die 脛nderung verl盲ngert Lucids Laufzeit r眉ckwirkend vom 30. Juni 2025 bis zum 31. Dezember 2025, sofern die Parteien keine weitere Verl盲ngerung vereinbaren.
Die 脛nderung stellt klar, dass, falls der Vertrag nicht anderweitig ge盲ndert oder verl盲ngert wird, Ladenburg Thalmann & Co. Inc. nach dem 31. Dezember 2025 als alleiniger Manager verbleiben wird. Das Unternehmen hat au脽erdem einen Prospektzusatz eingereicht (unter Bezugnahme auf den Zusatz vom 23. Mai 2024 und den Prospekt vom 1. Mai 2024) und die vollst盲ndige 脛nderung als Exhibit 10.1 beigef眉gt.
- Extension of Lucid's manager term under the ATM Agreement to December 31, 2025, preserving dual-manager capacity through year-end
- Prospectus supplement filed and Exhibit 10.1 attached, ensuring the amendment is publicly disclosed and the offering materials are updated
- None.
Insights
TL;DR: The Sixth ATM Amendment preserves dual-manager capability through year-end, maintaining the company's flexibility to raise capital via its ATM program.
The amendment explicitly extends Lucid's management role under the ATM Agreement to December 31, 2025, preserving the two-manager structure for cash-raising activities until that date. The filing of a prospectus supplement updates the public offering materials to reflect this change and includes the amendment as Exhibit 10.1. This keeps the company's previously established ATM framework operational and clarifies the transition plan should Lucid's role not be extended beyond year-end.
TL;DR: Governance update documents a contractual extension and contingency if Lucid's managerial role ends after December 31, 2025.
The Sixth ATM Amendment records a retrospective extension of Lucid's manager term to December 31, 2025, and specifies that absent further amendment Ladenburg will be the sole Manager thereafter. The company supplemented its prospectus materials to reflect the amendment and attached the full amendment as an exhibit, providing transparency about the parties' roles under the ATM Agreement.
Jaguar Health, Inc. ha annunciato il sesto emendamento al suo accordo di offerta At-The-Market (ATM) che estende il ruolo di Lucid Capital Markets, LLC come Manager nell'ambito dell'accordo. L'emendamento estende retroattivamente il periodo di Lucid dal 30 giugno 2025 al 31 dicembre 2025, salvo ulteriore proroga concordata dalle parti.
L'emendamento chiarisce che, qualora l'accordo non venga altrimenti modificato o prorogato, Ladenburg Thalmann & Co. Inc. rimarr脿 l'unico Manager dopo il 31 dicembre 2025. La societ脿 ha inoltre depositato un supplemento al prospetto (con riferimento al supplemento del 23 maggio 2024 e al prospetto del 1掳 maggio 2024) relativo all'emendamento, allegando il testo integrale dell'emendamento come Exhibit 10.1.
Jaguar Health, Inc. anunci贸 una sexta enmienda a su Acuerdo de Oferta At-The-Market (ATM) que ampl铆a el papel de Lucid Capital Markets, LLC como gestor dentro del acuerdo. La enmienda prorroga retroactivamente el plazo de Lucid desde el 30 de junio de 2025 hasta el 31 de diciembre de 2025, salvo que las partes acuerden una pr贸rroga adicional.
La enmienda aclara que, si el acuerdo no se modifica ni se ampl铆a de otro modo, Ladenburg Thalmann & Co. Inc. seguir谩 siendo el 煤nico gestor despu茅s del 31 de diciembre de 2025. La compa帽铆a tambi茅n present贸 un suplemento al prospecto (haciendo referencia al suplemento del 23 de mayo de 2024 y al prospecto del 1 de mayo de 2024) relacionado con la enmienda, y adjunt贸 la enmienda completa como Exhibit 10.1.
Jaguar Health, Inc.電� At-The-Market(ATM) 瓿惦瓿勳暯鞐� 雽�頃� 鞝�6彀� 靾橃爼鞎堨潉 氚滍憸頄堨溂氅�, 鞚� 靾橃爼鞎堨潃 頃措嫻 瓿勳暯鞐愳劀 Lucid Capital Markets, LLC鞚� 毵る媹鞝� 鞐暊鞚� 鞐办灔頃╇媹雼�. 靾橃爼鞎堨潃 2025雲� 6鞗� 30鞚�攵赌韯� 2025雲� 12鞗� 31鞚�旯岇 Lucid鞚� 旮瓣皠鞚� 靻岅笁頃橃棳 鞐办灔頃橂┌, 雼轨偓鞛愲摛鞚� 於旉岸� 鞐办灔鞐� 頃╈潣頃橃 鞎婋姅 頃� 鞙犿毃頃╇媹雼�.
靾橃爼鞎堨潃 瓿勳暯鞚� 雼Μ 靾橃爼霅橁卑雮� 鞐办灔霅橃 鞎婋姅 瓴届毎 Ladenburg Thalmann & Co. Inc.臧赌 2025雲� 12鞗� 31鞚� 鞚错泟鞐愲弰 雼弲 毵る媹鞝�搿� 雮姅雼る姅 鞝愳潉 氇呿檿頌� 頃╇媹雼�. 須岇偓電� 霕愴暅 頃措嫻 靾橃爼鞎堦臣 甏�霠悳 歃濌秾靹る獏靹� 氤挫订靹�(2024雲� 5鞗� 23鞚� 氤挫订靹� 氚� 2024雲� 5鞗� 1鞚� 歃濌秾靹る獏靹滊ゼ 彀胳“)毳� 鞝滌稖頃橁碃, 鞝勳泊 靾橃爼鞎堨潉 Exhibit 10.1搿� 觳秬頄堨姷雼堧嫟.
Jaguar Health, Inc. a annonc茅 un sixi猫me amendement 脿 son accord d'offre At-The-Market (ATM) qui prolonge le r么le de Lucid Capital Markets, LLC en tant que Manager dans le cadre de l'accord. L'amendement prolonge r茅troactivement la dur茅e de Lucid du 30 juin 2025 au 31 d茅cembre 2025, sauf accord des parties pour une prolongation suppl茅mentaire.
L'amendement pr茅cise que, si l'accord n'est pas modifi茅 ou prolong茅 autrement, Ladenburg Thalmann & Co. Inc. restera le seul Manager apr猫s le 31 d茅cembre 2025. La soci茅t茅 a 茅galement d茅pos茅 un suppl茅ment au prospectus (faisant r茅f茅rence au suppl茅ment du 23 mai 2024 et au prospectus du 1er mai 2024) relatif 脿 l'amendement, et a joint l'amendement complet en tant qu'Exhibit 10.1.
Jaguar Health, Inc. hat eine sechste 脛nderung ihres At-The-Market-(ATM)-Angebotsvertrags angek眉ndigt, die die Rolle von Lucid Capital Markets, LLC als Manager im Rahmen des Vertrags verl盲ngert. Die 脛nderung verl盲ngert Lucids Laufzeit r眉ckwirkend vom 30. Juni 2025 bis zum 31. Dezember 2025, sofern die Parteien keine weitere Verl盲ngerung vereinbaren.
Die 脛nderung stellt klar, dass, falls der Vertrag nicht anderweitig ge盲ndert oder verl盲ngert wird, Ladenburg Thalmann & Co. Inc. nach dem 31. Dezember 2025 als alleiniger Manager verbleiben wird. Das Unternehmen hat au脽erdem einen Prospektzusatz eingereicht (unter Bezugnahme auf den Zusatz vom 23. Mai 2024 und den Prospekt vom 1. Mai 2024) und die vollst盲ndige 脛nderung als Exhibit 10.1 beigef眉gt.
FAQ
What change did Jaguar Health (JAGX) report regarding its ATM agreement?
Who are the managers named in the ATM amendment for JAGX?
What happens after December 31, 2025 if the agreement is not further amended?
Did Jaguar Health update its prospectus in connection with the amendment?
Is the full amendment available in the filing?
